I-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 4, p. 725, doi. 10.1007/s00259-007-0652-6
- By:
- Publication type:
- Article
Works matching DE "GUANETHIDINE derivatives"
Results: 4
1
2
Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG).
- Published in:
- British Journal of Cancer, 1999, v. 79, n. 5/6, p. 793, doi. 10.1038/sj.bjc.6690127
- By:
- Publication type:
- Article
3
Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG).
- Published in:
- British Journal of Cancer, 1999, v. 79, n. 5/6, p. 802, doi. 10.1038/sj.bjc.6690128
- By:
- Publication type:
- Article
4
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.
- Published in:
- 2010
- By:
- Publication type:
- journal article